Revolution Medicines is a global oncology company focused on discovering, developing, and delivering medicines for patients with RAS-addicted cancers. The Senior Manager, Clinical Biomarker Operations (CBO), within Translational Medicine, provides biomarker operations expertise and develops scopes of work while maintaining effective relationships with cross-functional teams supporting Phase I–III clinical trials. The role operationalizes biomarker program strategies for early- and late-stage development across the company’s portfolio. The position leads end-to-end biomarker operations across oncology trials, including protocol reviews, prospective testing strategies, sample lifecycle oversight, data management, query resolution, and vendor qualification and contracting. It works with biomarker, bioinformatics, and companion diagnostic scientists and partners to align operational documents, testing strategies, sample handling, data transfers, and study delivery. The role also oversees central and specialty laboratory operations, vendor performance, budgets, timelines, quality, and regulatory compliance. The Senior Manager collaborates broadly across Clinical Development, Clinical Operations, Data Management, Quality Assurance, Regulatory Affairs, Procurement, Biospecimen Management, and external partners. The position supports Translational Medicine deliverables and regulatory submissions, manages and mentors junior CBO Leads, and serves as a subject matter expert for biomarker processes, SOP development, and operational improvements. It provides study metrics and updates to cross-functional teams and senior leadership.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior